Table 1.

Goal 1: enhance global access to strategies and agents that retard the progression of chronic kidney disease

Activities	Partners	Possible deliverables	Commentary
Development of early-stage CKD toolkit	Non-nephrology health care providers and health care politicians	CKD toolkits for different countries: •Distillation of generic summary •Generation of toolkit with multi-interventional, specific goals and simple interventions (simple measures: BP and urine dipstick) •Identification of workforce with capacity to deliver package •Translation into different languages	Needs to be adaptable in different workforces, health systems, and agents
Work toward global access to: 1)affordable BP–lowering drugs 2)glucose-lowering drugs 3)renin-angiotensin system blockade for proteinuric diabetic kidney disease, 4)statins for CVD prevention	WHO and regional health care providers	Monitor the availability of the 4 treatments and evaluate the implementation delta and publicize results Extend the GKHA36 project to include this monitoring Increase the availability of these agents or polypills for at risk populations
Develop and implement decision support tools		Create an inventory of existing decision support tools for early CKD by country Extend the GKHA36 project

BP, blood pressure; CKD, chronic kidney disease; CVD, cardiovascular disease; GKHA, Global Kidney Health Atlas; WHO, World Health Organization.